Article
29 Sep 2025
Development Of Therapeutic Protein Biosimilars - Can Startups Content With The "State Of The Art" Standard?
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United Kingdom
AUTHORS CONTENT
Article
25 Aug 2025
Client Beware: The Utilization Of Artificial Intelligence Platforms And The Potential Waiver Of Attorney-Client Privilege
Article
15 Aug 2025
Towards Trustworthy AI: Building Resilience Through Policy And Compliance
Article
22 Jul 2025
Trade Wars And Sanctions
Article
22 Jul 2025
Navigating AI In Business, Biotech, And Beyond
Article
03 Jun 2025
FTC Implements Rule To Eliminate Hidden Fees In Pricing
Article
03 Jun 2025
Recursive Artificial Intelligence: Can The Law Keep Up?
Article
28 Apr 2025
Supreme Court Expands Definition Of "Claims" Under The False Claims Act
Article
28 Apr 2025
Understanding FinCEN's Southwest Border Geographic Targeting Order For Money Service Businesses
Article
16 Apr 2025
FinCEN's New Interim Final Rule On Beneficial Ownership Information Reporting
Article
04 Feb 2025
Beneficial Ownership Reporting – To File Or Not To File?
Article
15 Jan 2025
9th Circuit Finds That Stromal Vascular Fraction (SVF) Procedures Constitute Treatments As Drugs
Article
26 Dec 2024
The New CFPB Small Business Lending Rule Moves Forward
Article
22 May 2023
Formation, Governance & Compliance: What Arizona Business Owners Should Know
Article
03 Apr 2023
Artificial Intelligence And The Implications For Drug Manufacturers (FDA Discussion)
Article
07 Oct 2022
The Capital Raise – Best Practices For Biotech
Article
27 Jul 2022
FDA Issues NDA And BLA Recommendations Warranting Real-Time Oncology Review
Article
14 Jul 2022
When Does "Puffery" Constitute Investor Fraud?